INVESTING IN
BREAKTHROUGH
HEALTH INNOVATIONS

Merck Global Health Innovation (GHI) invests in emerging companies that deliver breakthrough health care solutions, and which advance Merck's mission to discover, develop and provide innovative products and services that save and improve lives.

HOW WE INVEST

GHI invests in emerging companies that are offering breakthrough health care solutions in a number of high-growth fields. More >>

Investment Focus Areas

Global Health Innovation is developing a portfolio of opportunities in a number of key spaces, each of which has the potential to reshape health care in the years ahead. More >>

Forward Looking Statement

This presentation contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this presentation should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the risk factors and cautionary statements in Item 1A of Merck's Form 10-K for the year ended Dec. 31, 2010, and in any risk factors or cautionary statements contained in the Company's periodic reports on Form 10-Q or current reports on Form 8-K, which the Company incorporates by reference.